Results 111 to 120 of about 280,071 (239)

A predictive model for aggressive non-Hodgkin's lymphoma.

open access: yesNew England Journal of Medicine, 1993
M. Shipp   +26 more
semanticscholar   +1 more source

Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.

open access: yesJournal of Clinical Oncology, 2017
M. Davids   +20 more
semanticscholar   +1 more source

Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. [PDF]

open access: yes, 2019
Patients with human immunodeficiency virus (HIV) infection have a high risk of developing virally-mediated cancers. These tumors have several features that could make them vulnerable to immune checkpoint inhibitors (ICIs) including, but not limited to ...
Adashek, Jacob J   +3 more
core  

Intraoral Non-hodgkin′s Lymphoma In a HIV Patient

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2006
Non-Hodgkin′s lymphoma (NHL) is one of the most common malignancies associated with HIV infection. AIDS related NHL are primarily of the B cell phenotype with histological evidence of intermediate or high grade malignancy.
M Sunitha, S Shanmugam
doaj  

A case with non-Hodgkin lymphoma manifesting chylothorax and chylous ascites

open access: diamond, 1986
Hiromi Rakugi   +8 more
openalex   +2 more sources

Utility of DLCO Test in the Management and Follow-Up of Pneumocystosis in a Patient with Non-Hodgkin Lymphoma [PDF]

open access: gold, 2021
J. Espinoza Plaza   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy